The synthesis and chelation chemistry of DOTA-peptide conjugates.
about
Positron emission tomography imaging using radiolabeled inorganic nanomaterialsStability analysis of an inline peptide-based conjugate for metal delivery: nickel(II)-claMP Tag epidermal growth factor as a model system.Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design.Multimodality and nanoparticles in medical imagingTheranostic Gd(III)-lipid microbubbles for MRI-guided focused ultrasound surgery.PET imaging of leptin biodistribution and metabolism in rodents and primates.Assessment of blood flow with (68)Ga-DOTA PET in experimental inflammation: a validation study using (15)O-water.Optimization of time-resolved fluorescence assay for detection of europium-tetraazacyclododecyltetraacetic acid-labeled ligand-receptor interactions.Alternatives to gadolinium-based metal chelates for magnetic resonance imagingA New Synthesis of TE2A-a Potential Bifunctional Chelator for (64)Cu.Facile synthesis of non-ionic dimeric molecular resonance imaging contrast agent: its relaxation and luminescence studies.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Synthesis of a DOTA--biotin conjugate for radionuclide chelation via Cu-free click chemistry.Cyclic RGD Peptides Incorporating Cycloalkanes: Synthesis and Evaluation as PET Radiotracers for Tumor Imaging.Synthesis and characterization of a hypoxia-sensitive MRI probeInorganic chemistry in nuclear imaging and radiotherapy: current and future directions.Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with ⁹⁰Y and ¹¹¹In for domestic radioimmunotherapy and radioscintigraphy of non-Hodgkin's lymphomaEvaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptideHuman in vitro suppression as screening tool for the recognition of an early state of immune imbalanceThe remarkable stability of chimeric, sialic acid-derived alpha/delta-peptides in human blood plasma.Preparation, purification, and characterization of lanthanide complexes for use as contrast agents for magnetic resonance imaging.Fluorescent and lanthanide labeling for ligand screens, assays, and imaging.Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting(111)In- and (203)Pb-Labeled Cyclic RGD Peptide Conjugate as an α(v)β(3) Integrin-Binding RadiotracerSIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodiesGd(III)-DOTA-modified sonosensitive liposomes for ultrasound-triggered release and MR imaging.177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: synthesis, characterization and preliminary in vivo investigation in a pancreatic cancer model.Cyclotron Production of High-Specific Activity 55Co and In Vivo Evaluation of the Stability of 55Co Metal-Chelate-Peptide ComplexesAn amine-derivatized, DOTA-loaded polymeric support for Fmoc Solid Phase Peptide Synthesis(S)-5-(p-nitrobenzyl)-PCTA, a promising bifunctional ligand with advantageous metal ion complexation kinetics.IMPROVED SYNTHESIS OF 10-(2-ALKYLAMINO-2-OXOETHYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID DERIVATIVES BEARING ACID-SENSITIVE LINKERS.Radiometallated peptides for molecular imaging and targeted therapy.The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.Continuing pursuit for ideal systemic anticancer radiotherapeutics.Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.Targeting collagen for diagnostic imaging and therapeutic delivery.Metal based imaging probes of DO3A-Act-Met for LAT1 mediated methionine specific tumors: synthesis and preclinical evaluation.Design, synthesis, and in vitro evaluation of a binary targeting MRI contrast agent for imaging tumor cells.Cerenkov luminescence imaging of αv β6 integrin expressing tumors using (90) Y-labeled peptides.Synthesis of Gd and (68)Ga complexes in conjugation with a conformationally optimized RGD sequence as potential MRI and PET tumor-imaging probes.
P2860
Q28085340-7BE9AE60-59E6-4652-AE38-8F80FAFEC41DQ30366709-220F388A-B3F9-48A9-BA45-96156AA5988EQ30383551-022D98F1-E7AE-4F5B-AF65-CB8F56F89658Q30407070-42D370FD-D33B-4C1A-8EBF-768FE0C0899BQ30438087-F8480245-D7A2-4B35-A413-41BF991CD570Q30494418-FACF10DF-00A3-4BD9-AC0C-57CB5C6EA27CQ30854806-DE1EEBF5-732A-488D-AFE0-E6BA670608D7Q33512151-C7B88E84-FE77-48FB-94F5-87549BB7D2FDQ33557361-88BF0120-D4A7-463F-BF90-BB89FB3ABC40Q33704117-C457E1CC-AD20-450F-95A7-79B5B4E15BB4Q33828889-001FD628-8E8E-4A8C-A472-0ACC3F20A08DQ33847006-4600D0E2-760F-49F9-B702-6F7FEDB8509DQ34112403-12DBA652-FAC2-45B8-AA14-18D2081B369CQ34162650-BE04E503-5A23-4573-BEDE-79CB3577A5C9Q34319457-42536CFA-1B37-4361-9C83-9A6DE7168938Q34460892-6B61DDB3-EA41-4D92-9D38-A5D5A043A934Q34669139-7D24339D-9BD1-4AEC-9163-C87D1BD4BD31Q34870617-6A81442A-2A5F-4C22-9622-6B461FCF6360Q35379367-5982551E-10C5-4334-B1D7-BE20B8B9353BQ35857076-F099C5A8-019E-4EE8-9C19-2B508AE6E44BQ35940602-15A66247-BBBB-4CAB-A5B7-2FB36650E073Q36003339-185BB91D-8AED-4F0A-835C-92E42FE7974AQ36122563-EF01FDFE-AED7-4150-B909-92124444257FQ36393648-D2A18474-9B6B-4ABC-A562-F143E37D40B4Q36429037-9AE6E732-6F0D-4BAE-97C2-EAD43A588F76Q36465926-81B9047F-E1F7-4631-99C4-DF7357E39601Q36881050-42805749-6CC0-4197-8E4F-C5946E7466AAQ36890179-3BC33710-C60F-48D9-9A64-552BE14D589EQ37243272-4A37A1DA-98E6-44DF-933F-FA74CE6D516BQ37395793-05F5EAEC-3B02-49E9-8260-F32339C80948Q37400982-29A25FA0-35FD-4621-8584-8B491975547EQ37847064-BB8D027C-10F5-4EE4-AEED-BAEE472A10ECQ37850696-4159D866-4C44-4AF9-855A-C530994322E1Q37946750-6F7D675F-BF90-4F68-9209-E3798F0137EBQ38382330-0A5B9706-FC38-4A1D-A551-467F49516A79Q38698660-14D57CCD-02D8-45EC-ABEE-55270897023DQ38957923-F5DE9A14-98F5-4FF1-B655-E0EA7FD2D06DQ39035238-F2D3C001-3AA9-4632-85D5-0C639923A4E7Q39157017-286470A8-DAB3-4EB8-B0E5-AFA95A2D701BQ39367061-2FB3D20F-B00F-4576-A5C2-6AD4F74346F9
P2860
The synthesis and chelation chemistry of DOTA-peptide conjugates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The synthesis and chelation chemistry of DOTA-peptide conjugates.
@en
The synthesis and chelation chemistry of DOTA-peptide conjugates.
@nl
type
label
The synthesis and chelation chemistry of DOTA-peptide conjugates.
@en
The synthesis and chelation chemistry of DOTA-peptide conjugates.
@nl
prefLabel
The synthesis and chelation chemistry of DOTA-peptide conjugates.
@en
The synthesis and chelation chemistry of DOTA-peptide conjugates.
@nl
P356
P1476
The synthesis and chelation chemistry of DOTA-peptide conjugates.
@en
P2093
Luis M De León-Rodríguez
Zoltan Kovacs
P304
P356
10.1021/BC700328S
P577
2007-12-12T00:00:00Z